106 related articles for article (PubMed ID: 6137224)
1. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Jayaram HN; Ahluwalia GS; Dion RL; Gebeyehu G; Marquez VE; Kelley JA; Robins RK; Cooney DA; Johns DG
Biochem Pharmacol; 1983 Sep; 32(17):2633-6. PubMed ID: 6137224
[No Abstract] [Full Text] [Related]
2. The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Cooney DA; Jayaram HN; Gebeyehu G; Betts CR; Kelley JA; Marquez VE; Johns DG
Biochem Pharmacol; 1982 Jun; 31(11):2133-6. PubMed ID: 6126195
[No Abstract] [Full Text] [Related]
3. Comparative in vitro studies of Tiazofurin and a selenazole analog.
Streeter DG; Robins RK
Biochem Biophys Res Commun; 1983 Sep; 115(2):544-50. PubMed ID: 6138036
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.
Gebeyehu G; Marquez VE; Van Cott A; Cooney DA; Kelley JA; Jayaram HN; Ahluwalia GS; Dion RL; Wilson YA; Johns DG
J Med Chem; 1985 Jan; 28(1):99-105. PubMed ID: 2856943
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
[TBL] [Abstract][Full Text] [Related]
6. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
7. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA
Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide.
Kuttan R; Robins RK; Saunders PP
Biochem Biophys Res Commun; 1982 Aug; 107(3):862-8. PubMed ID: 6127996
[No Abstract] [Full Text] [Related]
9. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
10. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
[TBL] [Abstract][Full Text] [Related]
11. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
Yamada Y; Natsumeda Y; Weber G
Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase.
Gebeyehu G; Marquez VE; Kelley JA; Cooney DA; Jayaram HN; Johns DG
J Med Chem; 1983 Jun; 26(6):922-5. PubMed ID: 6133956
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of inosinate dehydrogenase.
Kuttan R; Saunders P
Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
[TBL] [Abstract][Full Text] [Related]
14. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
[TBL] [Abstract][Full Text] [Related]
15. Induced maturation of the human promyelocytic leukemia cell line, HL-60, by 2-beta-D-ribofuranosylselenazole-4-carboxamide.
Lucas DL; Robins RK; Knight RD; Wright DG
Biochem Biophys Res Commun; 1983 Sep; 115(3):971-80. PubMed ID: 6138039
[TBL] [Abstract][Full Text] [Related]
16. Dehydrogenase binding by tiazofurin anabolites.
Goldstein BM; Bell JE; Marquez VE
J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
[TBL] [Abstract][Full Text] [Related]
17. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.
Franchetti P; Cappellacci L; Perlini P; Jayaram HN; Butler A; Schneider BP; Collart FR; Huberman E; Grifantini M
J Med Chem; 1998 May; 41(10):1702-7. PubMed ID: 9572896
[TBL] [Abstract][Full Text] [Related]
18. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
Ikegami T; Natsumeda Y; Weber G
Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
[No Abstract] [Full Text] [Related]
19. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
Jayaram HN; Smith AL; Glazer RI; Johns DG; Cooney DA
Biochem Pharmacol; 1982 Dec; 31(23):3839-45. PubMed ID: 6130768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
